Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progression. Holliday MW Jr, Frost L, Navaneethan SD. Curr Opin Nephrol Hypertens 2024 Feb 26. doi: 10.1097/MNH.0000000000000976.

Read + Share

Amedeo Smart

Independent Medical Education

Holliday MW Jr, Frost L, Navaneethan SD. Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progression. Curr Opin Nephrol Hypertens 2024 Feb 26. doi: 10.1097/MNH.0000000000000976.
PMID: 38411162